We are live on
!
Find out more
HCM
Hillman Capital Management Portfolio holdings
AUM
$138M
1-Year Est. Return
8.57%
This Fund
S&P 500
This Quarter
Est. Return
-24.25%
1 Year Est. Return
+8.57%
3 Year Est. Return
+20.19%
5 Year Est. Return
+18.79%
10 Year Est. Return
–
AUM
$104M
AUM Growth
-$36.7M
(-26%)
Cap. Flow
+$3.98M
Cap. Flow
% of AUM
3.82%
Top 10 Holdings %
Top 10 Hldgs %
43.25%
Holding
53
New
3
Increased
20
Reduced
12
Closed
17
Avg Time Held
9.6
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
1.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$4.34M |
| 2 |
Becton Dickinson
BDX
|
+$3.33M |
| 3 |
Plains All American Pipeline
PAA
|
+$2.81M |
| 4 |
AB InBev
BUD
|
+$2.07M |
| 5 |
Simon Property Group
SPG
|
+$1.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$3.12M |
| 2 |
General Mills
GIS
|
+$3.12M |
| 3 |
Medtronic
MDT
|
+$2.48M |
| 4 |
GE Aerospace
GE
|
+$1.66M |
| 5 |
Lam Research
LRCX
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.36% |
| 2 | Consumer Discretionary | 12.34% |
| 3 | Consumer Staples | 11.99% |
| 4 | Communication Services | 8.77% |
| 5 | Financials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.71T
| $5.27M | 5.05% |
54,080
-1,120
| -2% | -$108K |
2019 Q4
1 quarter
|
|
2
Biogen
BIIB
$33B
| $5.18M | 4.96% |
16,380
-1,734
| -10% | -$526K |
2019 Q4
1 quarter
|
|
3
Microsoft
MSFT
$3.9T
| $4.94M | 4.74% |
31,349
-4,453
| -12% | -$732K |
2013 Q2
27 quarters
|
|
4
Bristol-Myers Squibb
BMY
$120B
| $4.73M | 4.53% |
84,930
-1,711
| -2% | -$105K |
2019 Q4
1 quarter
|
|
|
K
5
DELISTED
Kellanova
K
| $4.54M | 4.35% |
80,594
+892
| +1% | +$54.7K |
2019 Q4
1 quarter
|
|
|
SRCL
6
DELISTED
Stericycle Inc
SRCL
| $4.22M | 4.04% |
86,837
+8,557
| +11% | +$504K |
2019 Q4
1 quarter
|
|
7
CVS Health
CVS
$111B
| $4.21M | 4.03% |
70,920
-286
| -0.4% | -$19.1K |
2019 Q4
1 quarter
|
|
8
AT&T
T
$166B
| $4.08M | 3.91% |
185,369
+5,621
| +3% | +$154K |
2013 Q3
26 quarters
|
|
9
The Kraft Heinz Company
KHC
$25.9B
| $4.04M | 3.87% |
163,342
+4,695
| +3% | +$129K |
2019 Q4
1 quarter
|
|
|
10
AB InBev
BUD
$147B
| $3.94M | 3.77% |
89,201
+31,724
| +55% | +$2.07M |
2019 Q4
1 quarter
|
|
11
Goldman Sachs
GS
$260B
| $3.23M | 3.1% |
20,915
+54
| +0.3% | +$11.5K |
2013 Q2
27 quarters
|
|
12
Compass Minerals
CMP
$951M
| $3.2M | 3.06% |
83,118
+1,383
| +2% | +$75.3K |
2013 Q2
27 quarters
|
|
13
Enterprise Products Partners
EPD
$79.5B
| $3.12M | 2.99% |
218,009
+55,188
| +34% | +$1.28M |
2019 Q4
1 quarter
|
|
|
14
Becton Dickinson
BDX
$49.2B
| $3.02M | 2.9% |
+13,495
| New | +$3.33M |
2020 Q1
0 quarters
|
|
15
Verizon
VZ
$190B
| $2.98M | 2.85% |
55,368
+1,149
| +2% | +$65.7K |
2019 Q4
1 quarter
|
|
16
Merck
MRK
$344B
| $2.96M | 2.84% |
40,371
+3,210
| +9% | +$252K |
2013 Q2
27 quarters
|
|
17
DuPont de Nemours
DD
$17.6B
| $2.94M | 2.81% |
68,564
+31,414
| +85% | +$1.92M |
2019 Q4
1 quarter
|
|
18
Pfizer
PFE
$156B
| $2.93M | 2.81% |
94,585
+6,358
| +7% | +$217K |
2013 Q2
27 quarters
|
|
19
ExxonMobil
XOM
$674B
| $2.9M | 2.78% |
76,457
+10,286
| +16% | +$568K |
2013 Q2
27 quarters
|
|
20
Intel
INTC
$614B
| $2.9M | 2.77% |
53,511
-687
| -1% | -$40.6K |
2013 Q2
27 quarters
|
|
|
RTN
21
DELISTED
Raytheon Company
RTN
| $2.87M | 2.75% |
+21,900
| New | +$4.34M |
2020 Q1
0 quarters
|
|
22
Wells Fargo
WFC
$246B
| $2.82M | 2.7% |
98,104
+3,745
| +4% | +$159K |
2019 Q4
1 quarter
|
|
23
McDonald's
MCD
$165B
| $2.78M | 2.67% |
16,836
-91
| -0.5% | -$17.9K |
2019 Q4
1 quarter
|
|
24
Bank of America
BAC
$378B
| $2.78M | 2.66% |
130,785
+542
| +0.4% | +$16.2K |
2013 Q2
27 quarters
|
|
|
25
Simon Property Group
SPG
$65.2B
| $2.64M | 2.52% |
48,050
+16,257
| +51% | +$1.94M |
2019 Q4
1 quarter
|
|
Similar funds
PA
WA
EWP
FFG
AA
SWM
GI
ACM
Hillman Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Hillman Capital Management held 53 positions worth $104M, down 26% from $141M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Hillman Capital Management deployed $3.98M of net new capital in Q1 2020, opening 3 new positions and adding to 20 existing holdings. Its largest new stake was Raytheon Company: 21,900 shares worth $2.87M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Medtronic, an estimated $2.48M trimmed.
- Hillman Capital Management's largest Q1 2020 buy was Raytheon Company: 21,900 shares worth $2.87M.
- Hillman Capital Management added most to AB InBev in Q1 2020, an estimated $2.07M increase.
- Hillman Capital Management's biggest Q1 2020 reduction was Medtronic, cutting an estimated $2.48M.
- Hillman Capital Management fully exited IBM in Q1 2020, selling an estimated $3.12M.
- Hillman Capital Management's ten largest holdings make up 43% of its $104M portfolio in Q1 2020.
- Hillman Capital Management opened 3 new positions and closed 17 in Q1 2020.
- Hillman Capital Management's portfolio value fell 26% quarter-over-quarter to $104M.
Based on Hillman Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.